From Rous sarcoma virus to plasminogen activator, src oncogene and cancer management
- 7 March 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (27), 3003-3010
- https://doi.org/10.1038/onc.2011.38
Abstract
Plasminogen activator (PLAU) is a serine protease that converts plasminogen to plasmin, a general protease, which promotes fibrinolysis and degradation of extracellular matrix. PLAU was reported in 1970s as one of the robustly induced enzymatic activities in Rous sarcoma virus (RSV)-transformed chicken cells. More than three decades later, with the completion of the sequencing of the chicken genome and the subsequent availability of Affymetrix GeneChip genome arrays, several laboratories have surveyed the transcriptional program affected by the RSV transformation. Interestingly, the PLAU gene was shown to be the most highly upregulated transcript. The induction of PLAU was a transformation-dependent process because viruses with deleted Src gene did not induce the transcription of the PLAU gene. Both Src and PLAU genes are associated with and contribute to the complex phenotype of human cancer. Although the activity and structures of these two enzymes are well characterized, the precise molecular function of these gene products in signaling networks is still not fully understood. Yet, the knowledge of their association with cancer is already translated into the clinical setting. Src kinase inhibitors are being tested in clinical trials of cancer therapy, and PLAU gene and its inhibitor have been included as biomarkers with strong prognostic and therapeutic predictive values. This vignette reviews the history of PLAU and Src discovery, and illuminates the complexity of their relationship, but also points to their emerging impact on public health.Keywords
This publication has 61 references indexed in Scilit:
- Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA SplicingJournal of Biological Chemistry, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancerBMC Cancer, 2010
- Oncogenes and the Revolution in Cancer Research: Homage to Hidesaburo Hanafusa (1929-2009)Genes & Cancer, 2010
- The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signalingFEBS Letters, 2009
- Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding ProcessPublished by Elsevier BV ,2008
- Treatment for chronic myelogenous leukemia: the long road to imatinibJCI Insight, 2007
- Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-srcVirology, 2007
- Three-dimensional structure of the tyrosine kinase c-SrcNature, 1997
- Identification of a Ten-Amino Acid Proline-Rich SH3 Binding SiteScience, 1993